In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
Rosemarie Krupar*, Christian Watermann, Christian Idel, Julika Ribbat-Idel, Anne Offermann, Helen Pasternack, Jutta Kirfel, Andrew G. Sikora, Sven Perner
*Korrespondierende/r Autor/-in für diese Arbeit
15
Link öffnet neuen Tab
Zitate (Scopus)